Chan Zuckerberg Initiative announces Chicago biohub to study tissue inflammation

Katherine Lewin

News Reporter

A new biomedical research hub is coming to Chicago through an expansion of the CZ Biohub Network, a part of the Chan Zuckerberg Initiative.

The hub will be a collaboration between the University of Chicago, Northwestern University and the University of Illinois Urbana-Champaign to research and develop new technology to study inflammation in tissues. It will be funded with $250 million over the next decade from CZI, Forbes reported. Illinois Gov. JB Pritzker also committed $25 million in state money to support the hub.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

BECOME A PREMIUM SUBSCRIBER

Chan Zuckerberg Initiative announces Chicago biohub to study tissue inflammation

Katherine Lewin

News Reporter

Unlock this article instantly by becoming a free subscriber.

The next generation of AI biotechs is here. Can they deliver on the hype?

AbbVie beats first-quarter expectations, but Humira guidance leaves analysts confused

UCB makes major management changes; Bristol Myers’ ADC partner tops list of new CEOs

Updated: FDA approves Pfizer’s hemophilia B gene therapy, with $3.5M price tag

Bristol Myers to shutter Bay Area cell therapy facility as it eliminates jobs and costs

Ophthalmic biotech raises $16.5M; Pfizer’s AI collaboration bears fruit

Chan Zucker­berg Ini­tia­tive an­nounces Chica­go bio­hub to study tis­sue in­flam­ma­tion

Katherine Lewin

News Reporter

Unlock this article instantly by becoming a free subscriber.

more like this

The next gen­er­a­tion of AI biotechs is here. Can they de­liv­er on the hype?

Ab­b­Vie beats first-quar­ter ex­pec­ta­tions, but Hu­mi­ra guid­ance leaves an­a­lysts con­fused

UCB makes ma­jor man­age­ment changes; Bris­tol My­ers’ ADC part­ner tops list of new CEOs

Up­dat­ed: FDA ap­proves Pfiz­er’s he­mo­phil­ia B gene ther­a­py, with $3.5M price tag

Bris­tol My­ers to shut­ter Bay Area cell ther­a­py fa­cil­i­ty as it elim­i­nates jobs and costs

Oph­thalmic biotech rais­es $16.5M; Pfiz­er’s AI col­lab­o­ra­tion bears fruit

Chan Zuckerberg Initiative announces Chicago biohub to study tissue inflammation

The next generation of AI biotechs is here. Can they deliver on the hype?

AbbVie beats first-quarter expectations, but Humira guidance leaves analysts confused

UCB makes major management changes; Bristol Myers’ ADC partner tops list of new CEOs

Updated: FDA approves Pfizer’s hemophilia B gene therapy, with $3.5M price tag

Bristol Myers to shutter Bay Area cell therapy facility as it eliminates jobs and costs

Ophthalmic biotech raises $16.5M; Pfizer’s AI collaboration bears fruit